About FDA

ShaAvhrée Buckman-Garner, M.D., Ph.D., FAAP, Director, Office of Translational Sciences

Blue Bar


ShaAvhree Buckman

ShaAvhrée Buckman-Garner, M.D., Ph.D., FAAP is the Director of CDER's Office of Translational Sciences (OTS). OTS is comprised of the Office of Biostatistics, Office of Clinical Pharmacology, Office of Computational Science, Office of Study Integrity and Surveillance, provides oversight to CDER research involving human subjects, the CDER ORISE Program, as well as CDER regulatory science research. OTS is responsible for providing coordination for Critical Path initiatives across CDER in partnership with individual CDER offices.

Before joining OTS, Dr. Buckman-Garner served as Deputy Director for OTS and as medical team leader in CDER's Division of Pediatric Drug Development, Office of Counter Terrorism and Pediatric Drug Development. Dr. Buckman-Garner received her MD and PhD degrees with an emphasis on molecular cell biology from Washington University School of Medicine. She completed pediatric specialty training at Baylor College of Medicine.


 Footer graphic-CDER Leadership


Related Information

Page Last Updated: 05/19/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English